Top 10 Companies in the Southeast Asia Pharma Grade Soybean Oil Market (2026): Market Leaders Powering Regional Growth

MARKET INSIGHTS

Global Southeast Asia Pharma Grade Soybean Oil market was valued at USD 156.8 million in 2023 and is projected to reach USD 223.4 million by 2030, exhibiting a CAGR of 5.2% during the forecast period.

Pharma grade soybean oil is a highly refined vegetable oil that meets stringent pharmacopeia standards for purity and safety. This specialized oil serves as an excipient in pharmaceutical formulations, functioning as a solvent, emulsifier, or carrier for active pharmaceutical ingredients (APIs). The production process involves multiple purification steps including degumming, neutralization, bleaching, and deodorization to remove impurities and achieve required pharmaceutical specifications.

The market growth is driven by increasing pharmaceutical manufacturing in Southeast Asia, rising demand for parenteral nutrition formulations, and expanding applications in topical preparations. However, stringent regulatory requirements for pharmaceutical excipients and competition from alternative lipid-based carriers present challenges to market expansion. Recent innovations include the development of high‑oleic soybean oil variants offering improved oxidative stability for extended shelf‑life pharmaceutical products.

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

Top 10 Companies in the Southeast Asia Pharma Grade Soybean Oil Market (2026)

1️⃣ Cargill Incorporated

Headquarters: Minneapolis, USA
Key Offering: Pharma‑grade soybean oil for injection, oral, and topical applications

Cargill’s regional refinery network supports rapid distribution to pharmaceutical and nutraceutical manufacturers across Thailand, Vietnam, and Indonesia. The company leverages its global supply chain to secure high‑quality soybean feedstock, ensuring consistent purity and traceability.

Sustainability & Growth Initiatives: Investment in renewable processing technologies and carbon‑neutral production lines.

• Expansion of GMP‑certified facilities in Thailand (2025)
• Implementation of blockchain traceability for raw material sourcing
• Partnership with local universities for research on high‑oleic variants

2️⃣ Archer Daniels Midland Company

Headquarters: Chicago, USA
Key Offering: Ultra‑refined soybean oil meeting USP/EP standards

ADM’s integrated agricultural processing chain reduces cost volatility and supports a stable supply of pharma‑grade oil to Singapore and Malaysia’s contract manufacturers.

Sustainability & Growth Initiatives: Development of low‑peroxide refining processes and renewable energy sourcing.

• Launch of a dedicated pharma‑grade line in Malaysia (2024)
• Adoption of closed‑loop water recycling in refineries
• Collaboration with biotech firms for lipid‑nanoparticle formulations

3️⃣ AAK AB

Headquarters: Gothenburg, Sweden
Key Offering: Specialty oils for monoclonal antibody and vaccine adjuvant production

AAK’s specialty oils division focuses on meeting the highest pharmacopeia requirements, positioning the company as a preferred supplier for emerging biosimilar facilities in Singapore and Malaysia.

Sustainability & Growth Initiatives: Commitment to zero‑waste processing and renewable feedstock sourcing.

• Establishment of a new high‑purity line in Singapore (2025)
• Investment in AI‑driven quality control systems
• Strategic alliance with a leading vaccine manufacturer in Indonesia

4️⃣ IOI Corporation Berhad

Headquarters: Kuala Lumpur, Malaysia
Key Offering: GMP‑certified soybean oil for injectable and oral formulations

IOI’s vertically integrated palm‑and soybean‑processing operations enable cost‑effective production while maintaining strict quality benchmarks required for halal and pharmaceutical markets.

Sustainability & Growth Initiatives: Integration of sustainable palm oil practices and diversification into soybean.

• Launch of a new 200,000‑ton refinery in 2024
• Implementation of ISO 14001 environmental management
• Partnership with local farmers for non‑GMO soybean cultivation

5️⃣ Patum Vegetable Oil Co., Ltd.

Headquarters: Bangkok, Thailand
Key Offering: USP‑grade soybean oil for injection and softgel capsules

Patum’s proximity to Thailand’s pharmaceutical cluster provides a logistical advantage, reducing lead times for domestic and regional clients.

Sustainability & Growth Initiatives: Adoption of renewable energy sources in refining processes.

• Certification of a new GMP line in 2023
• Collaboration with Thai Ministry of Health on quality standards
• Investment in automated quality testing equipment

6️⃣ Wilmar International Limited

Headquarters: Singapore
Key Offering: High‑purity soybean oil for pharmaceutical and nutraceutical applications

Wilmar’s strategic location in Singapore positions the company to serve as a regional distribution hub for premium excipients.

Sustainability & Growth Initiatives: Focus on circular economy practices and renewable energy usage.

• Deployment of a solar‑powered refinery in Singapore (2025)
• Implementation of a digital traceability platform
• Partnership with a local biotech firm for cryopreservation media development

7️⃣ Musim Mas Holdings

Headquarters: Singapore
Key Offering: USP/EP‑grade soybean oil for injection and vaccine adjuvants

Musim Mas leverages its extensive palm‑oil portfolio to diversify into high‑purity soybean oil, catering to the growing demand for biopharmaceutical excipients.

Sustainability & Growth Initiatives: Commitment to sustainable palm oil certification and low‑carbon processes.

• Launch of a new high‑purity line in 2024
• Adoption of ISO 50001 energy management
• Collaboration with a leading vaccine developer in Indonesia

8️⃣ KLK Oleo

Headquarters: Kuala Lumpur, Malaysia
Key Offering: Specialty soybean oil for pharmaceutical and cosmetic applications

KLK Oleo’s focus on advanced purification technologies enables it to meet niche market requirements, particularly in the emerging field of lipid nanoparticles.

Sustainability & Growth Initiatives: Emphasis on renewable feedstock sourcing and waste minimization.

• Certification of a new GMP line in 2023
• Implementation of a closed‑loop water system
• Partnership with a local university for research on high‑oleic oils

9️⃣ Bunge Limited

Headquarters: Irving, Texas, USA
Key Offering: Pharma‑grade soybean oil for injection and oral formulations

Bunge’s extensive global supply chain and focus on quality control provide a reliable source of high‑purity oil for Southeast Asian manufacturers.

Sustainability & Growth Initiatives: Investment in low‑impact refining and renewable energy projects.

• Launch of a new GMP‑certified refinery in Vietnam (2025)
• Adoption of precision agriculture for soybean sourcing
• Collaboration with a leading contract manufacturer in Malaysia

🔟 Fuji Oil Holdings Inc.

Headquarters: Tokyo, Japan
Key Offering: Ultra‑refined soybean oil for injectable and vaccine formulations

Fuji Oil’s reputation for precision processing and strict quality standards makes it a trusted partner for high‑risk pharmaceutical applications in the region.

Sustainability & Growth Initiatives: Commitment to carbon neutrality and advanced waste‑to‑energy solutions.

• Establishment of a new high‑purity line in Singapore (2024)
• Implementation of a zero‑waste processing system
• Partnership with a leading biotech firm in Malaysia for lipid‑nanoparticle research

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

Southeast Asia Pharma Grade Soybean Oil Market – View in Detailed Research Report

Outlook: Regional Dynamics and Market Resilience

The next decade will see Southeast Asian manufacturers intensify localization efforts to reduce dependency on imported soybeans. Thailand’s 200,000‑ton refinery and Vietnam’s planned 150,000‑ton capacity are expected to meet roughly 60% of regional demand by 2030, shrinking lead times and buffering against global price swings. Concurrently, the region’s push for stricter pharmacopeia alignment will elevate the premium segment, as suppliers who can demonstrate compliance with USP/EP and local standards capture higher margins.

Emerging Trends Shaping the Market

• High‑oleic soybean oil variants with extended oxidative stability, enabling longer shelf life for mRNA vaccines and lipid‑nanoparticle drug delivery systems.
• Growth of biosimilar manufacturing hubs in Singapore and Malaysia, creating a steady stream of demand for high‑purity oil in monoclonal antibody and vaccine formulations.
• Adoption of digital traceability and blockchain for raw‑material provenance, enhancing confidence among regulatory bodies and end users.
• Expansion of contract manufacturing organizations (CMOs) into the region, increasing the need for reliable, GMP‑certified excipients.
• Continued emphasis on sustainability, with major players investing in renewable energy, closed‑loop water systems, and carbon‑neutral refining processes.